MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fneur.2025.1554841

Медицинская библиотека · Frontiers in neurology · 2025

Efficacy and exploratory analysis of potential mechanisms of stellate ganglion block in alleviating sleep disturbance in generalized anxiety disorder: a randomized controlled trial excluding comorbid depression.

Liu Na, Ma Qinying, Zhou Moqing, Yang Lin, Wang Wenyuan, Wang Yanyong

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To investigate the efficacy and mechanisms of stellate ganglion block (SGB) in treating generalized anxiety disorder (GAD) with sleep disturbance, excluding patients with comorbid depression.

METHODS

This double-blind randomized controlled trial (RCT) enrolled 128 patients with GAD (Hamilton Anxiety Scale [HAMA] > 14, Generalized Anxiety Disorder 7-item Scale [GAD-7] ≥ 5) and sleep disturbance (Pittsburgh Sleep Quality Index [PSQI] ≥ 15), randomized to receive SGB (n = 64, 4 ultrasound-guided 1% lidocaine injections) or conventional treatment (n = 64, cognitive behavioral therapy [CBT] + estazolam 1-2 mg/day). Outcomes included anxiety (HAMA), depression (Hamilton Depression Scale [HAMD]), sleep quality (PSQI), polysomnography (PSG), and neurotransmitter levels (norepinephrine [NE], serotonin [5-HT], neuropeptide Y [NPY]).

RESULTS

After 4 weeks, SGB demonstrated higher efficacy (98.4% vs. 89.1%, p = 0.028) and greater reductions in HAMA (9.36 ± 2.34 vs. 11.87 ± 2.71, p < 0.001) and HAMD scores (6.87 ± 2.01 vs. 8.09 ± 2.04, p < 0.001). PSQI improved significantly in the SGB group (5.74 ± 1.64 vs. 8.03 ± 1.86, p < 0.001), with increased total sleep time (TST) (429.76 ± 33.22 vs. 391.13 ± 30.76 min, p < 0.001) and efficiency (90.23 ± 13.29% vs. 86.34 ± 12.84%, p < 0.001). Neurotransmitter analysis showed reduced NE (289.43 ± 51.68 vs. 253.78 ± 57.12 pg./mL, p < 0.05) and increased 5-HT (138.56 ± 19.73 vs. 124.93 ± 18.44 ng/mL, p < 0.05) and NPY (453.21 ± 73.41 vs. 402.34 ± 68.12 pg./mL, p < 0.05). Adverse events were comparable (6.25% vs. 3.13%, p = 0.403).

CONCLUSION

SGB effectively improves GAD symptoms and sleep quality in patients without comorbid depression, potentially via modulation of NE, 5-HT, and NPY pathways. The exclusion of psychiatric comorbidities enhances the specificity of these findings.

Для цитирования: Liu Na, Ma Qinying, Zhou Moqing, Yang Lin, Wang Wenyuan, Wang Yanyong. Efficacy and exploratory analysis of potential mechanisms of stellate ganglion block in alleviating sleep disturbance in generalized anxiety disorder: a randomized controlled trial excluding comorbid depression.. Frontiers in neurology. 2025. DOI: 10.3389/fneur.2025.1554841.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.